Abstract

The Acinetobacter calcoaceticus-baumannii (Acb) complex is regarded as a group of phenotypically indistinguishable opportunistic pathogens responsible for mainly causing hospital-acquired pneumonia and bacteremia. The aim of this study was to determine the frequency of isolation of the species that constitute the Acb complex, as well as their susceptibility to antibiotics, and their distribution at the Hospital Infantil de Mexico Federico Gomez (HIMFG). A total of 88 strains previously identified by Vitek 2®, 40 as Acinetobacter baumannii and 48 as Acb complex were isolated from 52 children from 07, January 2015 to 28, September 2017. A. baumannii accounted for 89.77% (79/88) of the strains; Acinetobacter pittii, 6.82% (6/88); and Acinetobacter nosocomialis, 3.40% (3/88). Most strains were recovered mainly from patients in the intensive care unit (ICU) and emergency wards. Blood cultures (BC) provided 44.32% (39/88) of strains. The 13.63% (12/88) of strains were associated with primary bacteremia, 3.4% (3/88) with secondary bacteremia, and 2.3% (2/88) with pneumonia. In addition, 44.32% (39/88) were multidrug-resistant (MDR) strains and, 11.36% (10/88) were extensively drug-resistant (XDR). All strains amplified the blaOXA-51 gene; 51.13% (45/88), the blaOXA-23 gene; 4.54% (4/88), the blaOXA-24 gene; and 2.27% (2/88), the blaOXA-58 gene. Plasmid profiles showed that the strains had 1–6 plasmids. The strains were distributed in 52 pulsotypes, and 24 showed identical restriction patterns, with a correlation coefficient of 1.0. Notably, some strains with the same pulsotype were isolated from different patients, wards, or years, suggesting the persistence of more than one clone. Twenty-seven sequence types (STs) were determined for the strains based on a Pasteur multilocus sequence typing (MLST) scheme using massive sequencing; the most prevalent was ST 156 (27.27%, 24/88). The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas I-Fb system provided amplification in A. baumannii and A. pittii strains (22.73%, 20/88). This study identified an increased number of MDR strains and the relationship among strains through molecular typing. The data suggest that more than one strain could be causing an infection in some patient. The implementation of molecular epidemiology allowed the characterization of a set of strains and identification of different attributes associated with its distribution in a specific environment.

Highlights

  • The Acinetobacter genus includes species widely disseminated in nature, mostly in water and soil; some of these species are considered opportunistic pathogens that are relevant for their association with health-care associated infections (HAIs)

  • The eighty-eight strains firstly identified as A. baumannii and 48 as Acinetobacter calcoaceticus-baumannii complex (Acb) complex were reidentified with the MALDI-TOF-MS Biotyper, allowing us to differentiate between the species with the Acb complex

  • A. baumannii is an opportunistic pathogen that is associated with severe infections worldwide and is related to the different attributes that allow it to emerge as a nosocomial microorganism, i.e., mainly resistance to antibiotics and its ability to persist in hospital environments due to its ability to resist drying (Antunes et al, 2014; Harding et al, 2017)

Read more

Summary

Introduction

The Acinetobacter genus includes species widely disseminated in nature, mostly in water and soil; some of these species are considered opportunistic pathogens that are relevant for their association with health-care associated infections (HAIs). The Acinetobacter calcoaceticus-baumannii complex (Acb) harbored six species: A. calcoaceticus, A. baumannii, A. pittii, A. nosocomialis, Acinetobacter seifertii, and Acinetobacter dijkshoorniae (Gerner-Smidt et al, 1991; Nemec et al, 2011, 2015). A. baumannii is one of the most difficult bacteria to contain in a hospital environment It is included in the list of priority pathogens resistant to antibiotics, owing to the resistance it has acquired to different antibiotics such as carbapenems and cephalosporins limiting the therapeutic options for the treatment of infections caused by this pathogen (Higgins et al, 2010; Shrivastava et al, 2018)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call